Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lyprovite
- Development stage
- Unknown
- Lead developer
- Beacons Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lyprovite is a pediatric multivitamin and mineral syrup fortified with L-Lysine, developed and manufactured by Beacons Pharmaceuticals in Singapore. As a nutraceutical, it is designed to support the healthy growth and development of children by supplementing essential nutrients and managing vitamin and mineral deficiencies. The inclusion of L-Lysine, an essential amino acid, serves as an appetite stimulant; it facilitates metabolism by being converted into carnitine, which is utilized for energy production. The product is administered orally and is marketed as an over-the-counter consumer health supplement.
- Brand names
- Lyprovite
- Other names
- Lyprovite Syrup
Beyond the preview
Go deeper on Lyprovite.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lyprovite.